A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies	Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Disease Progression, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, skin disorder	Recruiting	Phase 1 / Phase 2	2025-05-01		NCT04503265

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AtlasMedx, Incorporated	1

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Johns Hopkins	Baltimore	United States	6
Scri Oncology Partners	Nashville	United States	156
The University of Texas MD Anderson Cancer Center	Houston	United States	207
University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology	Los Angeles	United States	1